Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNTR
1951
DELISTED
Pointer Telocation Ltd.
PNTR
| $3.77M | ﹤0.01% |
250,341
+100
| +0% | +$1.49K |
|
|
JCAP
1952
DELISTED
Jernigan Capital, Inc.
JCAP
| $3.75M | ﹤0.01% |
195,012
+184,712
| +1,793% | +$3.66M |
|
|
VCRA
1953
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $3.75M | ﹤0.01% |
152,100
-193,700
| -56% | -$5.03M |
|
1954
Strategy Inc
MSTR
$34.1B
| $3.74M | ﹤0.01% |
251,820
-472,180
| -65% | -$6.47M |
|
1955
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $3.73M | ﹤0.01% |
76,200
-63,400
| -45% | -$3.11M |
|
1956
AGCO
AGCO
$7.15B
| $3.73M | ﹤0.01% |
49,300
-315,100
| -86% | -$23.1M |
|
|
LADR
1957
Ladder Capital
LADR
$1.21B
| $3.73M | ﹤0.01% |
215,941
+125,500
| +139% | +$2.12M |
|
|
SGEN
1958
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.73M | ﹤0.01% |
+43,613
| New | +$3.2M |
|
1959
Airgain
AIRG
$73.4M
| $3.72M | ﹤0.01% |
316,310
+106,486
| +51% | +$1.33M |
|
|
CVLY
1960
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $3.72M | ﹤0.01% |
167,787
+1,764
| +1% | +$38.1K |
|
1961
Syndax Pharmaceuticals
SNDX
$1.69B
| $3.71M | ﹤0.01% |
497,000
+65,100
| +15% | +$593K |
|
1962
Emcor
EME
$35.2B
| $3.71M | ﹤0.01% |
43,100
-5,700
| -12% | -$485K |
|
1963
AMES National
ATLO
$271M
| $3.69M | ﹤0.01% |
129,000
+13,979
| +12% | +$379K |
|
1964
Dawson Geophysical
DWSN
$145M
| $3.69M | ﹤0.01% |
1,722,774
-2,621
| -0.2% | -$5.86K |
|
1965
LCNB Corp
LCNB
$282M
| $3.68M | ﹤0.01% |
207,416
+10,500
| +5% | +$184K |
|
1966
TTM Technologies
TTMI
$12B
| $3.67M | ﹤0.01% |
+300,869
| New | +$3.23M |
|
|
EMKR
1967
DELISTED
Emcore Corp
EMKR
| $3.66M | ﹤0.01% |
119,220
+8,515
| +8% | +$254K |
|
|
CNCE
1968
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.63M | ﹤0.01% |
617,790
+1,790
| +0.3% | +$19K |
|
1969
Chemung Financial Corp
CHMG
$393M
| $3.62M | ﹤0.01% |
86,288
+4,900
| +6% | +$214K |
|
1970
ePlus
PLUS
$2.42B
| $3.62M | ﹤0.01% |
95,200
+25,800
| +37% | +$995K |
|
1971
Euronet Worldwide
EEFT
$2.72B
| $3.62M | ﹤0.01% |
+24,745
| New | +$3.83M |
|
|
ITCL
1972
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $3.61M | ﹤0.01% |
323,200
+1,700
| +0.5% | +$19.9K |
|
1973
Superior Group of Companies
SGC
$185M
| $3.6M | ﹤0.01% |
223,300
+6,300
| +3% | +$98.3K |
|
|
LDL
1974
DELISTED
Lydall, Inc.
LDL
| $3.6M | ﹤0.01% |
144,400
+45,200
| +46% | +$965K |
|
|
BID
1975
DELISTED
Sotheby's
BID
| $3.6M | ﹤0.01% |
+63,100
| New | +$3.65M |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.